LYST was recently established as a gene of interest in patients with acute myeloid leukemia (AML), colorectal cancer, epithelial ovarian cancer, multiple myeloma, pulmonary carcinosarcoma, and sporadic chordoma (33–39). The gene discussed is LYST; the disease is plasma cell myeloma.